Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free DMRA Stock Alerts

Damora Therapeutics, Inc. Common Stock (DMRA) Short Interest Ratio & Short Volume

Damora Therapeutics, Inc. Common Stock logo
$21.01 -1.30 (-5.83%)
As of 06/5/2026 04:00 PM Eastern
Compare

Damora Therapeutics, Inc. Common Stock Short Interest Overview

As of May 15, 2026, Damora Therapeutics, Inc. Common Stock (DMRA) had a short interest of 1.29 million shares sold short, representing 2.11% of the public float. This marks a 8.37% increase in short interest since the prior report. The short interest ratio (days to cover) is 3.1, meaning it would take 3.1 days of the average trading volume of 322,141 shares to cover all short positions.

Current Short Interest
1,290,741 shares
Previous Short Interest
1,191,070 shares
Change Vs. Previous Month
8.37%
Dollar Volume Sold Short
$31.75 million
Short Interest Ratio
3.1 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
61,550,000 shares
Short Percent of Float
2.11%
Today's Trading Volume
523,534 shares
Average Trading Volume
322,141 shares
Today's Volume Vs. Average
163%
Short Selling Damora Therapeutics, Inc. Common Stock?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Damora Therapeutics, Inc. Common Stock and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

DMRA Short Interest Over Time

DMRA Days to Cover Over Time

DMRA Percentage of Float Shorted Over Time

Damora Therapeutics, Inc. Common Stock Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20261,290,741 shares $31.75 million +8.4%2.1%3.09 $24.60
4/30/20261,191,070 shares $30.56 million +6.7%2.0%5.51 $25.66
4/15/20261,116,620 shares $29.71 million +35.0%2.1%4.72 $26.61
3/31/2026827,221 shares $21.43 million +93.4%1.5%2.46 $25.90
3/13/2026427,713 shares $12.19 million +31.6%0.8%1.94 $28.50
2/27/2026325,076 shares $9.62 million +17.4%22.7%1.13 $29.58
2/13/2026277,004 shares $8.07 million +86.6%19.4%0.6 $29.12
1/30/2026148,474 shares $3.90 million -12.3%10.4%4.56 $26.24
1/15/2026169,350 shares $4.06 million -1.8%11.8%6.28 $23.95
12/31/2025172,444 shares $3.97 million -4.8%12.1%2.31 $23.01
12/15/2025181,086 shares $5.72 million +8.1%12.7%1.15 $31.60
11/28/2025167,465 shares $2.90 million -50.4%14.1%0.8 $17.35
11/14/2025337,430 shares $9.05 million +920.8%28.5%0.05 $26.83
10/31/202533,054 shares $241.96 thousand -62.9%2.8%0.33 $7.32
10/15/202589,100 shares $1.04 million -32.1%7.1%0 $11.68
9/30/2025131,200 shares $488.06 thousand +57.7%11.3%0.1 $3.72
9/15/202583,200 shares $235.46 thousand +560.3%7.3%0.1 $2.83
8/31/202512,600 shares $40.02 thousand -34.4%1.1%0.1 $3.18
8/15/202519,200 shares $65.38 thousand -30.2%1.7%0.9 $3.41
7/31/202527,500 shares $90.61 thousand -30.6%2.4%0.6 $3.30
7/15/202539,600 shares $140.58 thousand +7.3%3.5%0.9 $3.55
6/30/202536,900 shares $125.83 thousand -18.0%3.2%0.8 $3.41
6/15/202545,000 shares $150.75 thousand -40.4%4.0%0.5 $3.35
5/31/202575,500 shares $234.81 thousand +36.3%6.6%0.3 $3.11
5/15/202555,400 shares $161.21 thousand -20.4%4.9%0.2 $2.91
4/30/202569,600 shares $194.88 thousand +20.8%6.1%0.3 $2.80
4/15/202557,600 shares $148.03 thousand -11.0%5.1%0.2 $2.57
3/31/202564,700 shares $200.57 thousand +133.6%5.7%0.3 $3.10
3/15/202527,700 shares $112.19 thousand +51.4%2.4%0.1 $4.05
2/28/202518,300 shares $80.15 thousand -10.3%1.6%1 $4.38
2/15/202520,400 shares $97.51 thousand +56.9%1.8%1 $4.78
1/31/202513,000 shares $65 thousand -27.4%1.1%0.7 $5.00
1/15/202517,900 shares $86.28 thousand +6.6%1.6%0.9 $4.82
12/31/202416,800 shares $78.12 thousand -30.9%1.5%0.8 $4.65
12/15/202424,300 shares $123.44 thousand +20.3%2.1%0.9 $5.08
11/30/202420,200 shares $107.06 thousand +112.6%1.8%0.7 $5.30
11/15/20249,500 shares $60.42 thousand +97.9%0.8%0.2 $6.36
10/31/20244,800 shares $32.88 thousand -48.9%0.4%0.1 $6.85
10/15/20249,400 shares $63.26 thousand -36.1%0.9%0.3 $6.73
9/30/202414,700 shares $178.61 thousand +129.7%1.4%0.5 $12.15
June 12: $100 Turns Into $100,000? (Ad)

The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast. Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears.tc pixel

Click here to see how to get ahead of the SpaceX IPO
9/15/20246,400 shares $82.75 thousand -62.1%0.6%0.3 $12.93
8/31/202416,900 shares $201.96 thousand +98.8%1.9%1 $11.95
8/15/20248,500 shares $4.68 thousand +3.7%0.0%0.1 $0.55
7/31/20248,200 shares $4.62 thousand +173.3%0.0%0.1 $0.56
7/15/20243,000 shares $1.77 thousand -90.3%0.0%0 $0.59
6/30/202430,800 shares $14.61 thousand +1,084.6%0.2%0.2 $0.47
6/15/20242,600 shares $1.38 thousand -72.0%0.0%0 $0.53
5/31/20249,300 shares $5.65 thousand -80.4%0.1%0.1 $0.61
5/15/202447,400 shares $30.14 thousand -44.4%0.2%0.3 $0.64
4/30/202485,300 shares $58.77 thousand +373.9%0.4%0.4 $0.69
4/15/202418,000 shares $12.37 thousand -42.9%0.1%0.1 $0.69
3/31/202431,500 shares $24.57 thousand +74.0%0.2%0.1 $0.78
3/15/202418,100 shares $14.80 thousand -66.9%0.1%0 $0.82
2/29/202454,600 shares $39.32 thousand +39.6%0.3%0.1 $0.72
2/15/202439,100 shares $26.60 thousand -40.5%0.2%0.1 $0.68
1/31/202465,700 shares $40.21 thousand -53.0%0.3%0.2 $0.61
1/15/2024139,800 shares $96.18 thousand -54.3%0.7%0.4 $0.69
12/31/2023306,000 shares $220.32 thousand +332.2%1.6%0.8 $0.72
12/15/202370,800 shares $43.05 thousand -61.4%0.4%0.1 $0.61
11/30/2023183,400 shares $115.54 thousand -26.1%1.0%0.4 $0.63
11/15/2023248,000 shares $152.05 thousand -46.5%1.3%0.5 $0.61
10/31/2023463,900 shares $245.91 thousand -32.6%2.4%0.7 $0.53
10/15/2023688,500 shares $425.15 thousand -53.8%3.5%0.9 $0.62
9/30/20231,490,000 shares $1.07 million +337.5%7.0%2 $0.72
9/15/2023340,600 shares $201.87 thousand +95.8%1.6%0.7 $0.59
8/31/2023174,000 shares $105.27 thousand -55.9%0.8%0.4 $0.61
8/15/2023394,500 shares $265.70 thousand +73.0%2.0%1 $0.67
7/31/2023228,100 shares $702.55 thousand +403.5%1.2%1.3 $3.08
7/15/202345,300 shares $108.72 thousand -4.0%0.3%0.4 $2.40
6/30/202347,200 shares $118.94 thousand +271.7%0.3%0.7 $2.52
6/15/202312,700 shares $27.94 thousand +4.1%0.1%0.2 $2.20
5/31/202312,200 shares $26.60 thousand +3.4%0.1%0.2 $2.18
5/15/202311,800 shares $25.25 thousand -3.3%0.1%0.2 $2.14
4/30/202312,200 shares $21.47 thousand -63.8%0.1%0.2 $1.76
4/15/202333,700 shares $64.03 thousand +163.3%0.2%0.7 $1.90
3/31/202312,800 shares $25.47 thousand -25.6%0.1%0.3 $1.99
3/15/202317,200 shares $31.99 thousand -51.6%0.1%0.3 $1.86
2/28/202335,500 shares $77.75 thousand -47.6%0.2%0.7 $2.19
2/15/202367,700 shares $176.70 thousand +35.4%0.4%1.2 $2.61
1/31/202350,000 shares $115.00 thousand -40.7%0.3%0.8 $2.30
1/15/202384,300 shares $182.09 thousand +28.9%0.5%1.3 $2.16
12/30/202265,400 shares $75.21 thousand +127.9%0.4%1.1 $1.15
12/15/202228,700 shares $40.47 thousand +25.3%0.2%0.5 $1.41
11/30/202222,900 shares $35.95 thousand +2.7%0.1%0.4 $1.57
11/15/202222,300 shares $40.14 thousand -0.5%0.1%0.3 $1.80
10/31/202222,400 shares $45.02 thousand -47.5%0.1%0.3 $2.01
10/15/202242,700 shares $81.34 thousand -17.3%0.3%0.7 $1.91
9/30/202251,600 shares $97.52 thousand +32.3%0.3%0.9 $1.89
9/15/202239,000 shares $95.16 thousand -14.5%0.2%0.7 $2.44
8/31/202245,600 shares $98.04 thousand -9.7%0.3%0.8 $2.15
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
8/15/202250,500 shares $108.58 thousand -0.4%0.3%0.5 $2.15
7/31/202250,700 shares $81.63 thousand -11.1%0.3%0.5 $1.61
7/15/202257,000 shares $100.32 thousand +325.4%0.4%0.5 $1.76
6/30/202213,400 shares $23.18 thousand -68.2%0.1%0.1 $1.73
6/15/202242,100 shares $73.68 thousand -17.8%0.3%0.4 $1.75
5/31/202251,200 shares $67.07 thousand +85.5%0.3%0.4 $1.31
5/15/202227,600 shares $39.19 thousand +17.0%0.3%0.4 $1.42
4/30/202223,600 shares $39.65 thousand -60.9%0.2%0.4 $1.68
4/15/202260,300 shares $151.35 thousand +1.3%0.6%0.9 $2.51
3/31/202259,500 shares $130.90 thousand -35.0%0.6%0.8 $2.20
3/15/202291,500 shares $167.45 thousand +37.6%0.9%0.9 $1.83
2/28/202266,500 shares $123.03 thousand -26.4%0.6%0.5 $1.85
2/15/202290,300 shares $190.53 thousand -24.0%0.8%0.7 $2.11
1/31/2022118,800 shares $285.12 thousand +52.3%1.3%0.7 $2.40
1/15/202278,000 shares $188.76 thousand -41.7%N/A0 $2.42
12/31/2021133,700 shares $405.11 thousand +188.2%1.4%0.7 $3.03
12/15/202146,400 shares $110.43 thousand -16.3%0.5%0.2 $2.38
11/30/202155,400 shares $156.23 thousand -0.7%0.6%0.4 $2.82
11/15/202155,800 shares $195.86 thousand -21.9%0.6%0.4 $3.51
10/29/202171,400 shares $235.62 thousand +152.3%0.8%0.4 $3.30
10/15/202128,300 shares $96.79 thousand -41.4%0.3%0.2 $3.42
9/30/202148,300 shares $173.40 thousand -42.0%0.5%0.3 $3.59
9/15/202183,200 shares $348.61 thousand -16.6%0.9%0.3 $4.19
8/31/202199,700 shares $443.67 thousand -26.2%1.1%0.1 $4.45
8/13/2021135,100 shares $559.31 thousand -26.7%1.4%0.1 $4.14
7/30/2021184,300 shares $790.65 thousand -26.8%1.2%0.2 $4.29
7/15/2021251,700 shares $1.07 million -40.6%1.7%0.2 $4.27
6/30/2021423,600 shares $2.14 million +57.2%2.9%0.4 $5.06
6/15/2021269,500 shares $1.41 million +93.5%1.8%0.3 $5.25

DMRA Short Interest - Frequently Asked Questions

Short interest is the volume of Damora Therapeutics, Inc. Common Stock shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 1,290,741 shares of DMRA short. 2.11% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Learn More on Damora Therapeutics, Inc. Common Stock's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMRA shares currently have a short interest ratio of 3.1. Learn More on Damora Therapeutics, Inc. Common Stock's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.11% of Damora Therapeutics, Inc. Common Stock's floating shares are currently sold short.

Damora Therapeutics, Inc. Common Stock saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,290,741 shares, an increase of 8.4% from the previous total of 1,191,070 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.11% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Damora Therapeutics, Inc. Common Stock: Protagonist Therapeutics, Inc. (11.96%), Rhythm Pharmaceuticals, Inc. (12.84%), Centessa Pharmaceuticals PLC Sponsored ADR (1.72%), Cogent Biosciences, Inc. (7.04%), Belite Bio, Inc. Sponsored ADR (3.44%), Mirum Pharmaceuticals, Inc. (15.70%), TG Therapeutics, Inc. (20.55%), Scholar Rock Holding Corporation (15.08%), Grifols, S.A. (0.88%), CRISPR Therapeutics AG (29.57%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($80.71 billion), Invesco QQQ ($47.96 billion), iShares Russell 2000 ETF ($22.13 billion), Western Digital Corporation ($14.35 billion), Sandisk Corporation ($12.86 billion), Salesforce Inc. ($10.89 billion), Nebius Group N.V. ($9.92 billion), SPDR S&P Biotech ETF ($9.72 billion), Lumentum Holdings Inc. ($8.89 billion), and iShares 20+ Year Treasury Bond ETF ($8.18 billion). View all of the most shorted stocks.

Short selling DMRA is an investing strategy that aims to generate trading profit from Damora Therapeutics, Inc. Common Stock as its price is falling. DMRA shares are trading down $1.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Damora Therapeutics, Inc. Common Stock occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DMRA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMRA, twice per month. The most recent reporting period available is May, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like DMRA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:DMRA) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
How to get into the SpaceX IPO before June 12
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
This won't stay free
A few times a year, Bill Poulos makes his book Simple Options Trading for Beginners available at no cost. It n...
Profits Run | Sponsoredtc pixel